Japan relies almost entirely on China for the APIs of β-lactam antibiotics. These drugs are essential for treating infectious diseases…
HOME > ACADEMIA
ACADEMIA
- AMED Study Team Drafting First Guidelines for Diagnosis and Treatment of Post-Stroke Epilepsy
April 21, 2016
- 17 Japanese Medical Societies Jointly Recommend HPV Vaccines
April 20, 2016
- Positioning of Abraxane and Anti-PD-1 Antibodies Will Be Focus of Interest in Revised Guidelines for Gastric Cancer
March 23, 2016
- It’s Time to Discuss Restart of HPV Vaccine Promotion, Panel Chief Says as Personal View
March 16, 2016
- Biomarkers Urgently Needed to Tackle Ballooning Immunotherapy Costs: Oncologist
March 15, 2016
- Japan’s First Diabetes Management Guidelines for Elderly to Be Announced in May
March 11, 2016
- Development of AT2 Receptor-Related New Drugs Forging Ahead Overseas, but Japan Is “Far Behind”
February 22, 2016
- Sanofi, Univ. of Tokyo Form Strategic Partnership on Drug Discovery Research
February 19, 2016
- Discussions on New Guidelines for Atherosclerosis Prevention Get Underway
February 9, 2016
- Japan Oncology Society Calls for Proper Use of Opdivo
January 22, 2016
- Experts Launch Japanese Society of Geriatric Pharmacy
January 7, 2016
- Shionogi Funding Research to Develop World’s First Drug for Preventing Postoperative Metastasis of Lung Cancer
January 5, 2016
- Over 200 Medical Institutions, 14 Drug Makers Participating in Project to Analyze Cancer-Related Genetic Disorders
December 14, 2015
- Viekirax Joins Fray in Hep C Market, Can It Crack into Harvoni’s Stronghold?
November 20, 2015
- Japan Geriatrics Society to Publish Guidelines for Safe Pharmacotherapy in the Elderly Next Month
November 18, 2015
- Japan Sepsis Management Guidelines to Be Revised Next Year
October 27, 2015
- Group Calls for Appropriate Dosing of Dementia Drugs
October 9, 2015
- Asia, Oceania Obesity Associations Adopt Declaration on “Obesity Disease”
October 6, 2015
- New Guidelines for Obesity Treatment to Set Thresholds to Evaluate Drugs
October 6, 2015
- Japan Hypertension Society Announces COI Guide after Diovan Woes
October 5, 2015
ページ
Your company’s employer brand is your reputation as an employer and is crucial in attracting top talent. Some reputations are just not good; they may or not be deserved. That is just the perception in the market. Years ago there…
The Japanese government approved a bill to amend the Pharmaceuticals and Medical Devices (PMD) Act at its Cabinet meeting on…
Japan’s health ministry doled out regulatory approvals for a throng of new medicines on December 27 including Eli Lilly’s obesity…
Japan’s key reimbursement policy panel on December 25 approved an outline of the FY2025 drug price revision, finalizing plans to…
For the first time in many years, Japan appeared to have pivoted to a pro-innovation path with the FY2024 drug pricing reform. All eyes were apparently on this course change as seen in this year’s most-read story list, though the…
A Japanese health ministry panel discussing the generic industry structure on May 22 put together a report in which it…
The Ministry of Health, Labor and Welfare (MHLW) posted the final report compiled by its pharmaceutical regulation panel on its website on April 24, providing cases of drugs that could be exempted from all-case post marketing surveillance (PMS).The MHLW plans…
Japan’s all-important reimbursement policy panel on December 20 approved an outline of drug pricing reforms for FY2024, which enshrines a…
The Japanese health ministry’s expert panel tasked to discuss comprehensive policies for the rapid and stable supply of pharmaceuticals generally…